Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis

Suresh Ambati; Emma C. Ellis; Tuyetnhu Pham; Zachary A. Lewis; Xiaorong Lin; Richard B. Meagher

doi:10.1128/mBio.00030-21

mBio (Feb 2021)

Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis

Suresh Ambati,
Emma C. Ellis,
Tuyetnhu Pham,
Zachary A. Lewis,
Xiaorong Lin,
Richard B. Meagher

Affiliations

Suresh Ambati: Department of Genetics, University of Georgia, Athens, Georgia, USA
Emma C. Ellis: Department of Genetics, University of Georgia, Athens, Georgia, USA
Tuyetnhu Pham: Department of Microbiology, University of Georgia, Athens, Georgia, USA
Zachary A. Lewis: ORCiD; Department of Microbiology, University of Georgia, Athens, Georgia, USA
Xiaorong Lin: ORCiD; Department of Microbiology, University of Georgia, Athens, Georgia, USA
Richard B. Meagher: Department of Genetics, University of Georgia, Athens, Georgia, USA

DOI: https://doi.org/10.1128/mBio.00030-21
Journal volume & issue: Vol. 12, no. 1

Abstract

Read online

Invasive aspergillosis (IA) generally results from a pulmonary infection of immunocompromised patients by the common soil organism and opportunistic pathogen Aspergillus fumigatus

Published in mBio

ISSN: 2161-2129 (Print); 2150-7511 (Online)
Publisher: American Society for Microbiology
Country of publisher: United States
LCC subjects: Science: Microbiology
Website: https://journals.asm.org/journal/mbio

About the journal